霍乱

参考文献

关键文献

Sack DA, Sack RB, Nair GB, et al. Cholera. Lancet. 2004 Jan 17;363(9404):223-33. 摘要

Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet. 2012 Jun 3;379(9835):2466-76. 摘要

Das JK, Tripathi A, Ali A, et al. Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus. BMC Public Health. 2013 Sep 17;13(suppl 3):S11.全文  摘要

Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013 Dec;13(12):1050-6. 摘要

Ali M, Sur D, You YA, et al. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013 Apr;56(8):1123-31.全文  摘要

Leibovici-Weissman Y, Neuberger A, Bitterman R, et al. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev. 2014 Jun 19;(6):CD008625.全文  摘要

Nelson EJ, Nelson DS, Salam MA, et al. Antibiotics for both moderate and severe cholera. N Engl J Med. 2011 Jan 6;364(1):5-7.全文  摘要

参考文献

1. Sack DA, Sack RB, Nair GB, et al. Cholera. Lancet. 2004 Jan 17;363(9404):223-33. 摘要

2. Siddique AK, Nair GB, Alam M, et al. El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect. 2010 Mar;138(3):347-52. 摘要

3. World Health Organization. Fact sheet on cholera. Jan 2019 [internet publication].全文

4. Diop SA, Manga NM, Dia NM, et al. Cholera and pregnancy: epidemiological, clinical, and evolutionary aspects [in French]. Med Mal Infect. 2007 Dec;37(12):816-20. 摘要

5. Tran NT, Taylor R, Antierens A, et al. Cholera in pregnancy: a systematic review and meta-analysis of fetal, neonatal, and maternal mortality. 2015 Jul 15;10(7):e0132920.全文  摘要

6. World Health Organization. Cholera, 2015. Wkly Epidemiol Rec. 2016 Sep 23;91(38):433-40.全文  摘要

7. Ali M, Lopez AL, You YA, et al. The global burden of cholera. Bull World Health Organ. 2012 Mar 1;90(3):209-18A.全文  摘要

8. Ali M, Nelson AR, Lopez AL, et al. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003832. 摘要

9. Emch M, Feldacker C, Islam MS, et al. Seasonality of cholera from 1974 to 2005: a review of global patterns. Int J Health Geogr. 2008 Jun 1;7:31.全文  摘要

10. World Health Organization. Statement from UNICEF Executive Director Anthony Lake and WHO Director-General Margaret Chan on the cholera outbreak in Yemen as suspected cases exceed 200,000. Jun 2017 [internet publication].全文

11. Griffith DC, Kelly-Hope LA, Miller MA. Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg. 2006 Nov;75(5):973-7.全文  摘要

12. Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis. 2007 Aug;7(8):521-30. 摘要

13. World Health Organization. Ending cholera: a global roadmap to 2030. Oct 2017 [internet publication].全文

14. World Health Organization. Cholera, 2018. Wkly Epidemiol Rec. 2019 Nov 29;94(48):561-80.全文

15. World Health Organization. Cholera, 2007. Wkly Epidemiol Rec. 2008 Aug 1;83(31):269-83.全文  摘要

16. Mahalanabis D, Faruque AS, Albert MJ, et al. An epidemic of cholera due to Vibrio cholerae O139 in Dhaka, Bangladesh: clinical and epidemiological features. Epidemiol Infect. 1994 Jun;112(3):463-71. 摘要

17. Morris JG Jr. Cholera and other types of vibriosis: a story of human pandemics and oysters on the half shell. Clin Infect Dis. 2003 Jul 15;37(2):272-80.全文  摘要

18. Li M, Shimada T, Morris JG Jr, et al. Evidence for the emergence of non-O1 and non-O139 Vibrio cholerae strains with pathogenic potential by exchange of O-antigen biosynthesis regions. Infect Immun. 2002 May;70(5):2441-53.全文  摘要

19. Engel MF, Muijsken MA, Mooi-Kokenberg E, et al. Vibrio cholerae non-O1 bacteraemia: description of three cases in the Netherlands and a literature review. Euro Surveill. 2016 Apr 14;21(15).全文  摘要

20. Holbourn KP, Shone CC, Acharya KR. A family of killer toxins: exploring the mechanism of ADP-ribosylating toxins. FEBS J. 2006 Oct;273(20):4579-93.全文  摘要

21. Paneth N. Assessing the contributions of John Snow to epidemiology: 150 years after removal of the broad street pump handle. Epidemiology. 2004 Sep;15(5):514-6. 摘要

22. Ries AA, Vugia DJ, Beingolea L, et al. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec;166(6):1429-33. 摘要

23. Motarjemi Y, Käferstein F, Moy G, et al. Contaminated weaning food: a major risk factor for diarrhoea and associated malnutrition. Bull World Health Organ. 1993;71(1):79-92.全文  摘要

24. Gundry S, Wright J, Conroy R. A systematic review of the health outcomes related to household water quality in developing countries. J Water Health. 2004 Mar;2(1):1-13. 摘要

25. Wright J, Gundry S, Conroy R. Household drinking water in developing countries: a systematic review of microbiological contamination between source and point-of-use. Trop Med Int Health. 2004 Jan;9(1):106-17.全文  摘要

26. Rabbani GH, Greenough WB 3rd. Food as a vehicle of transmission of cholera. J Diarrhoeal Dis Res. 1999 Mar;17(1):1-9. 摘要

27. Albert MJ. Epidemiology and molecular biology of Vibrio cholerae O139 Bengal. Indian J Med Res. 1996 Jul;104:14-27. 摘要

28. Hashizume M, Wagatsuma Y, Faruque AS, et al. Factors determining vulnerability to diarrhoea during and after severe floods in Bangladesh. J Water Health. 2008 Sep;6(3):323-32. 摘要

29. Evans CA, Gilman RH, Rabbani GH, et al. Gastric acid secretion and enteric infection in Bangladesh. Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):681-5. 摘要

30. Nalin DR, Levine RJ, Levine MM, et al. Cholera, non-vibrio cholera, and stomach acid. Lancet. 1978 Oct 21;2(8095):856-9. 摘要

31. Richterman A, Sainvilien DR, Eberly L, et al. Individual and household risk factors for symptomatic cholera infection: a systematic review and meta-analysis. J Infect Dis. 2018 Oct 15;218(suppl 3):S154-64.全文  摘要

32. Berger SA, Young NA, Edberg SC. Relationship between infectious diseases and human blood type. Eur J Clin Microbiol Infect Dis. 1989 Aug;8(8):681-9. 摘要

33. Cohen MB, Giannella RA, Losonsky GA, et al. Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139. Infect Immun. 1999 Dec;67(12):6346-9.全文  摘要

34. Harris JB, Khan AI, LaRocque RC, et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun. 2005 Nov;73(11):7422-7.全文  摘要

35. Palmer DL, Koster FT, Alam AK, et al. Nutritional status: a determinant of severity of diarrhea in patients with cholera. J Infect Dis. 1976 Jul;134(1):8-14. 摘要

36. von Seidlein L, Wang XY, Macuamule A, et al. Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique. Trop Med Int Health. 2008 May;3(5):683-8.全文  摘要

37. Colombara DV, Cowgill KD, Faruque AS. Risk factors for severe cholera among children under five in rural and urban Bangladesh, 2000-2008: a hospital-based surveillance study. PLoS One. 2013;8(1):e54395.全文  摘要

38. Sinclair D, Abba K, Zaman K, et al. Oral vaccines for preventing cholera. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD008603.全文  摘要

39. Saha A, Chowdhury MI, Khanam F, et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine. 2011 Oct 26;29(46):8285-92. 摘要

40. Sur D, Kanungo S, Sah B, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011 Oct;5(10):e1289.全文  摘要

41. Phares CR, Date K, Travers P, et al. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand. Vaccine. 2016 Jan 2;34(1):128-33.全文  摘要

42. Qadri F, Ali M, Chowdhury F, et al. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial. Lancet. 2015 Oct 3;386(10001):1362-71. 摘要

43. Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet. 2012 Jun 3;379(9835):2466-76. 摘要

44. Clemens JD, Nair GB, Ahmed T, et al. Cholera. Lancet. 2017 Sep 23;390(10101):1539-49. 摘要

45. Bi Q, Ferreras E, Pezzoli L, et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2017 Oct;17(10):1080-8.全文  摘要

46. Lopez AL, Deen J, Azman AS, et al. Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and metaanalysis. Clin Infect Dis. 2018 Jun 1;66(12):1960-71.全文  摘要

47. Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis. 2006 Jun;6(6):361-73. 摘要

48. Sur D, Lopez AL, Kanungo S, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009 Nov 14;374(9702):1694-702. 摘要

49. Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN. Review of oral cholera vaccines: efficacy in young children. Infect Drug Resist. 2011 Sep 14;4:155-60.全文  摘要

50. Das JK, Tripathi A, Ali A, et al. Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus. BMC Public Health. 2013 Sep 17;13(suppl 3):S11.全文  摘要

51. Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013 Dec;13(12):1050-6. 摘要

52. International Medical Corps (IMC) & International Rescue Committee (IRC). Guidance note on the use of oral cholera vaccines. Mar 2016 [internet publication].全文

53. World Health Organization. Cholera vaccines: WHO position paper - Recommendations. Vaccine. 2010 Jul 5;28(30):4687-8. 摘要

54. Martin S, Lopez AL, Bellos A, et al. Post-licensure deployment of oral cholera vaccines: a systematic review. Bull World Health Organ. 2014 Dec 1;92(12):881-93.全文  摘要

55. Ali M, Sur D, You YA, et al. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013 Apr;56(8):1123-31.全文  摘要

56. Centers for Disease Control and Prevention. Clinical update: cholera vaccine for travelers. Mar 2020 [internet publication].全文

57. Libman M, CATMAT. Summary of the Committee to Advise on Tropical Medicine and Travel (CATMAT) statement on travellers' diarrhea. Can Commun Dis Rep. 2015 Nov 5;41(11):272-84.全文  摘要

58. Wong KK, Burdette E, Mahon BE, et al. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine. MMWR Morb Mortal Wkly Rep. 2017 May 12;66(18):482-5. 摘要

59. Chen WH, Cohen MB, Kirkpatrick BD, et al. Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor. Clin Infect Dis. 2016 Jun 1;62(11):1329-35.全文  摘要

60. Cabrera A, Lepage JE, Sullivan KM, et al. Vaxchora: a single-dose oral cholera vaccine. Ann Pharmacother. 2017 Jul;51(7):584-9. 摘要

61. Graves PM, Deeks JJ, Demicheli V, et al. Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected). Cochrane Database Syst Rev. 2010 Aug 4;(8):CD000974.全文  摘要

62. Vugia DJ, Rodriguez M, Vargas R, et al. Epidemic cholera in Trujillo, Peru 1992: utility of a clinical case definition and shift in Vibrio cholerae O1 serotype. Am J Trop Med Hyg. 1994 May;50(5):566-9. 摘要

63. Swerdlow DL, Ries AA. Cholera in the Americas. Guidelines for the clinician. JAMA. 1992 Mar 18;267(11):1495-9. 摘要

64. Sack DA, Tacket CO, Cohen MB, et al. Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun. 1998 May;66(5):1968-72.全文  摘要

65. Kaushik JS, Gupta P, Faridi MM, et al. Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial. Indian Pediatr. 2010 Apr;47(4):309-15. 摘要

66. Chatterjee A, Mahalanabis D, Jalan KN, et al. Plasma specific gravity and haematocrit values as indices of the degree of dehydration in infantile diarrhoea. Indian J Med Res. 1979 Aug;70:229-32. 摘要

67. Cook GC. Gastroenterological emergencies in the tropics. Baillieres Clin Gastroenterol. 1991 Dec;5(4):861-86. 摘要

68. Wang F, Butler T, Rabbani GH, et al. The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med. 1986 Dec 18;315(25):1591-5. 摘要

69. Centers for Disease Control and Prevention. Laboratory testing for cholera. Jul 2018 [internet publication].全文

70. Mandell, GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. New York, NY: Elsevier/Churchill Livingstone; 2005.

71. Nato F, Boutonnier A, Rajerison M, et al. One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Vaccine Immunol. 2003 May;10(3):476-8.全文  摘要

72. Ramamurthy T, Pal A, Bag PK, et al. Detection of cholera toxin gene in stool specimens by polymerase chain reaction: comparison with bead enzyme-linked immunosorbent assay and culture method for laboratory diagnosis of cholera. J Clin Microbiol. 1993 Nov;31(11):3068-70.全文  摘要

73. Mundy LS, Shanholtzer CJ, Willard KE, et al. An evaluation of three commercial fecal transport systems for the recovery of enteric pathogens. Am J Clin Pathol. 1991 Sep;96(3):364-7. 摘要

74. Harris JR, Cavallaro EC, de Nobrega AA, et al. Field evaluation of crystal VC(R) rapid dipstick test for cholera during a cholera outbreak in Guinea-Bissau. Trop Med Int Health. 2009 Sep;114(9):1117-21. 摘要

75. Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of epidemic dysentery and cholera. 1999 [internet publication].全文

76. Shirai H, Nishibuchi M, Ramamurthy T, et al. Polymerase chain reaction for detection of the cholera enterotoxin operon of Vibrio cholerae. J Clin Microbiol. 1991 Nov;29(11):2517-21. [Erratum in: J Clin Microbiol. 1992 Jun;30(6):1620.]全文  摘要

77. Khuntia HK, Pal BB, Chhotray GP. Quadruplex PCR for simultaneous detection of serotype, biotype, toxigenic potential, and central regulating factor of Vibrio cholerae. J Clin Microbiol. 2008 Jul;46(7):2399-401.全文  摘要

78. Yamazaki W, Seto K, Taguchi M, et al. Sensitive and rapid detection of cholera toxin-producing Vibrio cholerae using a loop-mediated isothermal amplification. BMC Microbiol. 2008 Jun 12;8:94.全文  摘要

79. Ryan U, Paparini A, Oskam C. New technologies for detection of enteric parasites. Trends Parasitol. 2017 Jul;33(7):532-46. 摘要

80. Saha D, Karim MM, Khan WA, et al. Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med. 2006 Jun 8;354(23):2452-62.全文  摘要

81. Weil AA, Khan AI, Chowdhury F, et al. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis. 2009 Nov 15;49(10):1473-9.全文  摘要

82. Faruque AS, Mahalanabis D, Islam A, et al. Common diarrhea pathogens and the risk of dehydration in young children with acute watery diarrhea: a case-control study. Am J Trop Med Hyg. 1993 Jul;49(1):93-100. 摘要

83. Alam M, Hasan NA, Sultana M, et al. Diagnostic limitations to accurate diagnosis of cholera. J Clin Microbiol. 2010 Nov;48(11):3918-22. 摘要

84. WHO Global Task Force on Cholera Control. Acute diarrhoeal diseases in complex emergencies: critical steps. 2010 [internet publication].全文

85. Musekiwa A, Volmink J. Oral rehydration salt solution for treating cholera: <= 270 mOsm/L solutions vs >= 310 mOsm/L solutions. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003754.全文  摘要

86. Gregorio GV, Gonzales ML, Dans LF, et al. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2016 Dec 13;(12):CD006519.全文  摘要

87. Roy SK, Islam A, Ali R, et al. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):460-2. 摘要

88. Kabir I, Khan WA, Haider R, et al. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children. J Diarrhoeal Dis Res. 1996 Dec;14(4):243-7. 摘要

89. Leibovici-Weissman Y, Neuberger A, Bitterman R, et al. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev. 2014 Jun 19;(6):CD008625.全文  摘要

90. Nelson EJ, Nelson DS, Salam MA, et al. Antibiotics for both moderate and severe cholera. N Engl J Med. 2011 Jan 6;364(1):5-7.全文  摘要

91. Centers for Disease Control and Prevention. Recommendations for the use of antibiotics for the treatment of cholera. Jan 2015 [internet publication].全文

92. Williams PCM, Berkley JA. Guidelines for the management of paediatric cholera infection: a systematic review of the evidence. Paediatr Int Child Health. 2018 Nov;38(suppl 1):S16-31.全文  摘要

93. Alam AN, Alam NH, Ahmed T, et al. Randomised double blind trial of single dose doxycycline for treating cholera in adults. BMJ. 1990 Jun 23;300(6740):1619-21.全文  摘要

94. Khan WA, Bennish ML, Seas C, et al. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139. Lancet. 1996 Aug 3;348(9023):296-300. 摘要

95. Roy SK, Hossain MJ, Khatun W, et al. Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial. BMJ. 2008 Feb 2;336(7638):266-8.全文  摘要

96. Canani RB, Cirillo P, Buccigrossi V, et al. Zinc inhibits cholera toxin-induced, but not Escherichia coli heat-stable enterotoxin-induced, ion secretion in human enterocytes. J Infect Dis. 2005 Apr 1;191(7):1072-7.全文  摘要

97. World Health Organization. Vitamin A supplementation in infants and children 6-59 months of age. 2011 [internet publication].全文

98. Ghana VAST Study Team. Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality. Lancet. 1993 Jul 3;342(8862):7-12. 摘要

99. Bhandari N, Bahl R, Sazawal S, et al. Breast-feeding status alters the effect of vitamin A treatment during acute diarrhea in children. J Nutr. 1997 Jan;127(1):59-63.全文  摘要

100. Imdad A, Mayo-Wilson E, Herzer K, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2017 Mar 11;(3):CD008524.全文  摘要

101. Utsalo SJ, Eko FO, Umoh F, et al. Faecal excretion of Vibrio cholerae during convalescence of cholera patients in Calabar, Nigeria. Eur J Epidemiol. 1999 Apr;15(4):379-81. 摘要

102. Echevarría J, Seas C, Carrillo C, et al. Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera. Clin Infect Dis. 1995 Jun;20(6):1480-4. 摘要

103. Reveiz L, Chapman E, Ramon-Pardo P, et al. Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis. PLoS One. 2011 Nov 15;6(11):e27060.全文  摘要

内容使用需遵循免责声明